Trial intelligence / Profile preview

Subcutaneous vs vaginal progesterone for luteal phase support in IVF

2007-006595-11Phase 3Completed

Sponsor
IBSA Group
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of progesterone in female infertility and infertility (2 arms), sponsored by IBSA Group. Primary endpoint: Ongoing pregnancy rate at 10 weeks of luteal support. Started Jun 2008; status: completed.

02

Drugs

progesterone
03

Conditions

female infertilityinfertility

Beyond the preview

Go deeper on 2007-006595-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006595-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call